mots c vs tirzepatide Understanding the Difference: While both peptides are powerful metabolic tools, their pharmacology is distinct: • (Manjaro): This is a dual agonist targeting GLP-1 (Glucagon-like peptide-1) and GIP (Glucose-dependent insulinotropic MOTS-c Dosage: Cycle, Reconstitution &
Description
However, some patients have successfully submitted receipts to their insurance company or HSA/FSA for partial reimbursement
Why tirzepatide and not just semaglutide
People who continued tirzepatide lost an additional 5.5% of body weight over the following year
Expected Results Timeline Setting realistic expectations helps maintain motivation and perspective throughout this protocol
Both medications stimulate the GLP-1 receptor, which increases intestinal water secretion and speeds colonic transit
